Clinical Trial Update: Pharmacokinetics and Safety of Evogliptin in Subjects With Hepatic Dysfunction [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic and safety study of Evogliptin in adults with hepatic dysfunction has completed, assessing how liver impairment affects drug exposure an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Dysfunction

Drugs mentioned

• Evogliptin (evogliptin)

Snippet

Sponsor: Dong-A ST Co., Ltd. | Conditions: Liver Dysfunction | Phase 1 | Status: COMPLETED